Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

NCT04461223 · clinicaltrials.gov ↗

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Cardiotoxicity
Osteosarcoma
Myocardial Injury
Chemotherapy Induced Systolic Dysfunction
Doxorubicin Induced Cardiomyopathy

Interventions

DIAGNOSTIC_TEST: contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM Aera 1.5T)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University